Literature DB >> 23977536

Novel radiation therapy approaches in malignant pleural mesothelioma.

Andreas Rimner1, Kenneth E Rosenzweig.   

Abstract

Entities:  

Year:  2012        PMID： 23977536      PMCID： PMC3741784          DOI： 10.3978/j.issn.2225-319X.2012.10.07

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  29 in total

1.  Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series.

Authors:  Sandro Tonoli; Paola Vitali; Vieri Scotti; Filippo Bertoni; Luigi Spiazzi; Barbara Ghedi; Fabrizio Banci Buonamici; Livia Marrazzo; Gabriele Guidi; Icro Meattini; Paolo Bastiani; Maurizio Amichetti; Marco Schwarz; Stefano Maria Magrini
Journal:  Radiother Oncol       Date:  2011-11-11       Impact factor: 6.280

2.  Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.

Authors:  Jerôme Krayenbuehl; Susanne Oertel; J Bernard Davis; I Frank Ciernik
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

3.  Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.

Authors:  Florian Sterzing; Gabriele Sroka-Perez; Kai Schubert; Marc W Münter; Christian Thieke; Peter Huber; Jürgen Debus; Klaus K Herfarth
Journal:  Radiother Oncol       Date:  2008-01-18       Impact factor: 6.280

4.  Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.

Authors:  Malcolm Feigen; Sze Ting Lee; Catherine Lawford; Katheryn Churcher; Eddy Zupan; Andrew M Scott; Chris Hamilton
Journal:  J Med Imaging Radiat Oncol       Date:  2011-06       Impact factor: 1.735

5.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

6.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

7.  Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Claus Andrup Kristensen; Trine Juhler Nøttrup; Anne Kiil Berthelsen; Flemming Kjaer-Kristoffersen; Jesper Ravn; Jens Benn Sørensen; Svend-Aage Engelholm
Journal:  Radiother Oncol       Date:  2009-04-11       Impact factor: 6.280

8.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

9.  Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.

Authors:  Edward F Miles; Nicole A Larrier; Christopher R Kelsey; Jessica L Hubbs; Jinli Ma; Sua Yoo; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-08       Impact factor: 7.038

10.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316
View more
  9 in total

1.  Three-dimensional finite-element based deformable image registration for evaluation of pleural cavity irradiation during photodynamic therapy.

Authors:  Rozhin Penjweini; Michele M Kim; Timothy C Zhu
Journal:  Med Phys       Date:  2017-05-24       Impact factor: 4.071

2.  Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

Authors:  Andreas Rimner; Marjorie G Zauderer; Daniel R Gomez; Prasad S Adusumilli; Preeti K Parhar; Abraham J Wu; Kaitlin M Woo; Ronglai Shen; Michelle S Ginsberg; Ellen D Yorke; David C Rice; Anne S Tsao; Kenneth E Rosenzweig; Valerie W Rusch; Lee M Krug
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.

Authors:  Semi B Harrabi; Stefan A Koerber; Sebastian Adeberg; Sonja Katayama; Klaus Herfarth; Juergen Debus; Florian Sterzing
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-11

4.  Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.

Authors:  Marcher R Thompson; Vishruta A Dumane; Stanislav A Lazarev; Yaseen Zia; Kenneth E Rosenzweig
Journal:  Pract Radiat Oncol       Date:  2019-01-15

5.  Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.

Authors:  Christina Leitzen; Timo Wilhelm-Buchstab; Sabina Stumpf; Martina Heimann; David Koch; Christopher Schmeel; Birgit Simon; Susanne Vornholt; Stephan Garbe; Fred Röhner; Felix Schoroth; Hans Heinz Schild; Heinrich Schüller; Thomas Müdder
Journal:  Strahlenther Onkol       Date:  2019-03-26       Impact factor: 3.621

6.  Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.

Authors:  Kwan-Chang Kim; Hong-Phuc Vo
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

7.  Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.

Authors:  Andreas Rimner; Daniel E Spratt; Marjorie G Zauderer; Kenneth E Rosenzweig; Abraham J Wu; Amanda Foster; Ellen D Yorke; Prasad Adusumilli; Valerie W Rusch; Lee M Krug
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-26       Impact factor: 7.038

8.  Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs.

Authors:  LiCheng Kuo; Ellen D Yorke; Vishruta A Dumane; Amanda Foster; Zhigang Zhang; James G Mechalakos; Abraham J Wu; Kenneth E Rosenzweig; Andreas Rimner
Journal:  J Appl Clin Med Phys       Date:  2016-05       Impact factor: 2.102

Review 9.  Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies.

Authors:  Sotiris Papaspyros; Sayonara Papaspyros
Journal:  ISRN Surg       Date:  2014-02-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.